Recent Development and Future Aspects: Nano-Based Drug Delivery System in Cancer Therapy

Sasireka Rajendran,Sai Nandhini Ravi,Vaishnavi M. Nair,R. Pooja Sree,Azhagu Saravana Babu Packirisamy,Jeyanthi Palanivelu

DOI: https://doi.org/10.1007/s11244-023-01893-6

IF: 2.781

2024-01-03

Topics in Catalysis

Abstract:The rapid advancement of nanotechnology in the production of nanomedicine agents holds enormous promise for improving cancer therapy techniques. Nanomedicine products offer the possibility of developing complex targeting approaches as well as multifunctionality. Nanotechnology has been examined for the detection of extracellular cancer biomarkers and cancer cells, as well as in vivo imaging, sensitive and selective, accuracy, and multiplexed detection capacity. In fact, nanoparticles have the potential to not only address the limitations of traditional cancer diagnosis and treatment, but also to open up entirely new possibilities and develop cutting-edge technology for tumour detection and treatment. Nano carriers are used to increase target tumour cell specificity and delivery capability to the tumour site, enhancing therapy efficacy while reducing unwanted side effects. Nanocarriers that respond to exogenous or endogenous stimuli have emerged as a promising alternative to target drug delivery. In this review intervention of nanoparticle system for cancer types like Lung cancer, Breast cancer, Melanoma, Colorectal cancer, Bladder cancer are discussed. Further focused on the advancement of nanocarriers for cancer diagnosis and treatment. The critical review takes deeper insight on nanocarrier-based cancer therapy.

chemistry, physical, applied